Castle Creek Biosciences
PrivateLast Round
Debt
Feb 25, 2025
Total Funding Raised
$198M
Momentum Score
25 /100
Company Overview
Castle Creek Biosciences is a biotechnology company that develops a fibroblast technology platform to create personalized cell and gene therapies aimed at addressing the root causes of diseases in patients with high unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Castle Creek Biosciences Comps
Public and private peers based on sector, stage, and business model.
Castle Creek Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 25, 2025 | ||||
| VC Round | May 25, 2022 | ||||
| Debt | Mar 25, 2020 | ||||
| Series C | Mar 25, 2020 | ||||
| Series B | Sep 29, 2016 |
Castle Creek Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ligand Pharmaceuticals | Debt |
| Fidelity Management & Research Company | VC Round, Series C, Series B |
| Paragon Biosciences | VC Round, Debt, Series C |
| Horizon Technology Finance Corporation | Debt |
| Valor Equity Partners | VC Round, Debt, Series C |
| XOMA Royalty Corporation | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Lead candidate for dystrophic epidermolysis bullosa (DEB) enters pivotal trial.
- Apr 1, 2025
Lead candidate for DEB moves to pivotal Phase 3 trial, nearing BLA filing.
Castle Creek Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Castle Creek Biosciences's valuation, stock price, and market status.
